ZS Stock: Buy or Sell? Price Target & Forecast

ZS Zscaler Inc As of Sep 3, 2026

$172.73

High-growth SaaS showing revenue strength but profitability headwinds; valuation at inflection point after 49% YTD decline.

Setup: Recovery / Inflection Watch Confidence: 58 Horizon: 3-6 months Risk: medium-high Category: Growth SaaS / Cybersecurity

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals ZS's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

34.8% YoY revenue growth + 5Y CAGR of 44% demonstrate strong cloud security TAM capture. Gross margin 76.9% shows pricing power. Strategic CrowdStrike partnership (just announced) unlocks cross-domain integration and distribution. Stock down 49% from 52W high—deep value for growth cohort. FCF positive. Current ratio 2.0 provides runway.

▼ Bear Case

Operating margin -4.8%, net margin -1.6% signal path to profitability unclear. Stock down 49% YTD amid broader SaaS selloff and macro risk-off. Insider selling heavily outweighs buying (56 sells vs 13 buys; 1.9M net shares sold). P/S 10.3x, P/B 24.7x remain elevated for unprofitable SaaS. Competition from Palo Alto, Fortinet, Check Point intensifying.

Valuation

OVERVALUED on absolute metrics, FAIR-TO-RICH on growth-adjusted basis — score 42/100

P/S 10.3x is elevated for unprofitable SaaS even with 34.8% revenue growth. P/B 24.7x reflects heavy intangible value. Price-to-FCF 37.7x is expensive. However, 5Y revenue CAGR 44% and gross margin 76.9% justify premium vs. low-growth peers. Valuation anchored to profitability inflection narrative; if margin improvement stalls, downside risk material.

Technical Levels

Support · $160.00 (Recent pivot / entry zone floor) · $155.00 (3-month support / stop-loss zone) · $140.00 (Bear-case target)

Resistance · $177.60 (Today's high) · $185.00 (3-month range midpoint) · $200.00 (Psychological / bull-case threshold) · $220.00 (Bull-case target)

RSI: Not available in payload

Financial Health

Score 72/100. Balance sheet is clean: current + quick ratios >1.9 suggest ample liquidity to fund operations and growth. No red flags on leverage. Profitability structure is the vulnerability, not solvency. ZS can sustain this margin profile for several more years if FCF remains positive, but investor patience finite.

Catalysts

Q2 2024 Earnings (date TBD in payload)	Next ~4–6 weeks	HIGH — guidance & margin trajectory are key. Beat on EPS/revenue + margin guidance raise = +10–15% move. Miss on guidance = -10–15%.
CrowdStrike / Zscaler partnership execution (integrations, co-sell wins)	Ongoing; milestones likely in earnings calls / Analyst Day	MEDIUM — validates strategic positioning. Early wins could drive NRR uplift & upside EPS revisions.
Operating margin inflection (path to profitability)	Q2–Q3 2024 guidance / management commentary	HIGH — if roadmap credible, re-rating to 10–12x P/S possible; if delayed, downside to $140–$150.
Macro / Fed rate signal	FOMC meetings (Jun, Jul, Sep 2024)	MEDIUM — SaaS cohort sensitivity to rates remains elevated. Harder-than-expected landing = pressure on ZS; soft-landing narrative = support.

Risk Flags

Operating & net margins deeply negative; profitability timeline unclear from available data.

Insider selling 10.5x buy volume; no executive accumulation signal.

SaaS cohort remains under pressure; macro and rate headwinds could extend drawdown.

P/E ratio unavailable; forward guidance not in payload—cannot assess earnings quality.

EVoEBITDA nonsensical (-212x) due to EBITDA losses; ratio not meaningful.

52-week range $114.62–$336.99 reflects extreme volatility; large gap to current reflects 2024 bear move.

See ZS's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock ZS free →

More Analyses

NVDA

AAPL

TSLA

MSFT

AMZN

GOOGL

ZS FAQ

Is ZS a buy right now?

Zscaler Inc's current read is a Recovery / Inflection Watch setup with 58 confidence over a 3-6 months horizon. Valuation: OVERVALUED on absolute metrics, FAIR-TO-RICH on growth-adjusted basis. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is ZS overvalued?

OVERVALUED on absolute metrics, FAIR-TO-RICH on growth-adjusted basis (valuation score 42/100). P/S 10.3x is elevated for unprofitable SaaS even with 34.8% revenue growth. P/B 24.7x reflects heavy intangible value. Price-to-FCF 37.7x is expensive. However, 5Y revenue CAGR 44% and gross margin 76.9% justify premium vs. low-growth peers. Valuation anchored to profitability inflection narrative; if margin improvement stalls, downside risk material.

What are the risks of buying ZS?